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Abstract
Spontaneous preterm delivery is linked to intrauterine inflammation. Fetal membranes are involved in the inflammatory process as
an important source of mediators, and the chorion leave produces high levels of the pro-inflammatory cytokine TNF  whenα
stimulated by LPS. The transcription factor NF- B is the main regulator of this inflammatory process and controls the production ofκ
cytokines by the chorion leave. PDE4 inhibitors are recognized for their anti-inflammatory and myorelaxant effects. The purpose of
this study was to investigate whether PDE4 inhibition affects the LPS signaling in human cultured chorionic cells. We showed that
these cells express TLR4, the main LPS receptor, and exhibit a predominant PDE4 activity. Upon LPS challenge, PDE4 activity
increases concomitantly to the induction of the specific isoform PDE4B2 and chorionic cells secrete TNF . LPS induces the nuclearα
translocation of the NF- B p65 subunit and the activation of three different NF- B complexes in chorionic cells. The presence of theκ κ
PDE4 inhibitor rolipram reduces the TNF  production and the activation of the three NF-K B complexes. These data indicate thatα κ
the PDE4 family interacts with the LPS signaling pathway during the inflammatory response of chorionic cells. PDE4 selective
inhibitors may thus represent a new therapeutic approach in the management of inflammation-induced preterm delivery.
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Introduction
Despite great strides in improving the survival of infants born prematurely (before 37 weeks of postmenstrual age), preterm birth still
accounts for 70  of neonatal deaths and up to 75  of neonatal morbidities. A causal link has been established between preterm delivery% %
and infection ( ). Microorganisms are often isolated from the amniotic cavity of women with preterm labor ( ) and the intraamniotic or1 2 
intrauterine injection of LPS or heat-killed bacteria is sufficient to promote preterm delivery in mouse, rabbit, and sheep ( ). Infection3 
triggers a local inflammation in the gestational tissues, initiating production of cytokines, prostaglandins, and metalloproteases ( ).4 –6 
Among the gestational tissues, the amniochorionic membranes are an important source of cytokines, chemokines and prostaglandins. Of
particular interest is the chorionic membrane; it is the largest area of contact with the maternal tissues and it is the first tissue colonized by
microbial pathogens during an ascending intrauterine infection. , human choriodecidua produces 10 fold higher level of theIn vitro 
pro-inflammatory cytokines TNF  and MCP-1 than human amnion ( , ).α 7 8 
LPS signals through ligation to TLR4 ( ) and activates the transcription factor NF- B, a dimer of two subunits, typically p65 and p509 κ
( ). NF- B has been shown to control the LPS-induced production of pro-inflammatory cytokines by human amnion and choriodecidua (10 κ
), as well as activation of the phospholipase A2, an enzyme implicated in the metabolism of prostaglandins ( ). Moreover, genetic11 12 
ablation of TLR4 or pharmacologic inhibition of NF- B prevents LPS-induced preterm delivery in mice ( , ).κ 9 13 
The onset and progression of the inflammatory response are sensitive to changes in the steady-state level of the cyclic nucleotide,
cAMP ( ). Pharmacological manipulation of cyclic nucleotide phosphodiesterases (PDE) , which degrade the cyclic nucleotides cAMP14  3 
and cGMP, provides a powerful mean of regulation of the biological processes relayed by these intracellular second messengers ( ).15 
Among the eleven families of mammalian PDE described to date, the PDE4 family specifically hydrolyzes cAMP and is predominant in
all immunocompetent cells ( ). Selective PDE4 inhibitors reduce the production of chemokines, pro-inflammatory cytokines, and16 
adhesion molecules in leukocytes, endothelial, and airway epithelial cells ( ). The PDE4s are encoded by four genes (A, B, C and D)17 
which generate at least 20 different isoforms. It has been pointed out a role for the PDE4B isoforms in inflammation, as KO micepde4b 
are hyporesponsiveness to LPS and resistant to septic shock ( ), and a particular function has been given to the short form PDE4B2,18 
predominant in leukocytes and induced by LPS in macrophages ( ).19 
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Recently, we have shown that PDE4 inhibition by rolipram, the archetypal PDE4 inhibitor, blocked a LPS-inducedin vivo 
inflammation at the feto-maternal interface and prevented subsequent preterm delivery and fetal demise in mice ( ). Persistent20 
intrauterine inflammation was concomitant with nuclear localisation of NF-K B in a specific set of murine cells at the vicinity of maternalκ
cells and PDE4 inhibition prevented the NF- B nuclear translocation. Furthermore, we evidenced in a previous study that PDE4 was theκ
main PDE family expressed in human fetal membranes and PDE4 activity was increased by LPS ( ). PDE4 inhibitors blocked the21 
release of pro-inflammatory cytokines, prostaglandins, and metalloproteases induced by LPS in these membranes.
In the light of these data, the chorion leave of the fetal membranes is likely to have an integrative part in determining the severity and
the extent of the intrauterine inflammation. Therefore, we investigated in this study the ability of cultured human chorionic cells to develop
an inflammatory response when challenge with LPS and whether PDE4 are implicated in the control of this response.
Materials and Methods
Primary culture of human chorionic cells
Chorionic cells were prepared using a modification of the technique described by Kliman et al ( ). Placentas were obtained from non22 
laboring women after a normal term (> 37 weeks of gestation) singleton-pregnancy delivered by elective caesarean section. This study was
approved by the  Comit  Consultatif de Protection des Personnes pour la Recherche Biom dicale  (Paris-Cochin, France) and informed« é é »
consent was obtained from all donors. Briefly, fetal membranes were dissected from placenta under sterile conditions and chorion with
adherent decidua was peeled off amnion and placed in PBS. After the removal of blood clots, chorion was cut in small pieces and digested
with 0.5  trypsin (Sigma, St Louis, MO) and 0.2  collagenase B (Roche Diagnostics, Mannheim, Germany) in DMEM-F12 (Invitrogen,% %
Cergy-Pontoise, France) at 37 C for 3h. After the addition of DMEM-F12 containing 5  FCS and 100 M EDTA, the cell suspension was° % μ
filtered through a 100 m nylon gauze and centrifuged at 400 g for 10 min. The cell pellet, resuspended in complete medium (DMEM-F12μ
containing 5  FCS, 2.5 g/ml amphotericin, 100 IU/ml penicillin (Invitrogen), 100 g/ml streptomycin (Invitrogen), 1x Insulin% μ μ
Transferrin Selenium and 0.02 g/ml Epidermal Growth Factor), was loaded onto a continuous Percoll gradient (40  Percoll, 10  HBSS,μ % %
10 mM Hepes, Sigma) and centrifuged at 1,200 g for 20 min. Cells that accumulate around 1/3 superior of the tube were collected and
incubated on a Petri dish coated with monoclonal antibodies against human HLA class I for 20 min, to remove the maternal cells ( ).23 
Unattached cells were pelleted by centrifugation, resuspended in complete medium and plated at a density of 10 cells/cm for5 2 
immunocytochemistry and immunofluorescence analysis, and at a density of 2.10 cells/cm for other experiments on dishes coated with5 2 
collagen type I 5 g/cm , and cultured in complete medium for three days at 37 C in 5  CO and 95  air before experimentation. Forμ 2 ° % 2 %
some experiments, macrophages or mesenchymal cells were immuno-depleted using CD45 monoclonal antibodies or vimentin monoclonal
using the Dynabeads system according to the manufacturer s instructions. Chorionic cells were transferred to serum-deprived medium 2h’
before treatment and then incubated with 100 ng/ml LPS at 37 C, with or without 10 M rolipram for the indicated times.° 5 −
U937 cells
U937 cells, obtained from ATCC, were cultured in RPMI supplemented with 10  FCS and 2 mM glutamine, at 37 C in 5  CO and% ° % 2 
95  air. U937 cells were differentiated in macrophages with 100 nM PMA for 48h and then replaced in fresh medium without PMA for%
24h.
Assessment of the chorionic cells preparation purity by immunofluorescence
Chorionic cells were cultured in 24-well dishes on collagen-coated glass coverslips. After fixation for 15 min with 4%
para-formaldehyde in PBS, for binding of CK7 and vimentin antibodies, cells were permeabilized by incubation in 0.1  Triton X-100 in%
10  FCS PBS for 15 min and for binding of CD45 antibodies, cells were incubated in 10  FCS PBS without Triton for 15 min.% – % –
Incubation with primary monoclonal antibodies directed against CK7 (dilution 1:500, DakoCytomation, Carpinteria, CA), vimentin
(dilution 1:500, DakoCytomation) and CD45 (dilution 1:500, DakoCytomation) was performed overnight at 4 C. Incubation with°
secondary antibodies was performed with the anti-mouse IgG1 TRITC-labeled solution (dilution 1:1200, SouthernBiotech, Birmingham,
AL) for 45 min at RT. Nuclei were labeled with Hoechst 33342, diluted 1:500 in water for 2 min. Coverslips were mounted on slides using
fluorescent mounting medium (DakoCytomation). Negative controls were carried out by using mouse IgG1.
Quantitative analysis of the NF- B p65 nuclear translocation by immunofluorescenceκ
Chorionic cells were cultured in 24-well dishes on collagen-coated glass coverslips. After fixation for 15 min with 4%
para-formaldehyde in PBS, cells were permeabilized by incubation in 0.1  Triton X-100 in 10  FCS PBS for 15 min. Incubation with% % –
primary antibodies directed against NF- B p65 (dilution 1:500, sc-109, Santa Cruz Biotechnology) was performed overnight at 4 C.κ °
Incubation with secondary antibodies was performed with the Alexa Fluor R-488 donkey anti-rabbit IgG FITC-labeled solution (dilution
1:500, Interchim, Montlu on, France) for 45 min at RT. Nuclei were labeled with Hoechst 33342, diluted 1:500 in water for 2 min.ç
Coverslips were mounted on slides using fluorescent mounting medium (DakoCytomation). Negative controls were carried out by using a
non immune rabbit serum.
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For quantitative analysis, total and unlabelled nuclei were counted in six distinct random fields per coverslip. The difference
corresponds to nuclei containing NF- B p65. The result was expressed in percentage of labelled nuclei. All coverslips were counted by aκ
single investigator for internal consistency. Random fields were counted by a blinded independent investigator for external verification of
the results.
Cell lysates and nuclear extracts
For whole lysates of chorionic cells, cells were homogenized in ice-cold buffer (50 mM NaCl, 25mM Hepes, 2.5 mM EDTA, 50 mM
NaF, 3 mM Na P O , 0.5 mM Na VO , 10  glycerol, 1  NP 40 and a protease inhibitor cocktail (P2714, Sigma)) for 15 min on ice.4 2 7 3 4 % %
Homogenates were centrifuged for 5 min at 14,000 g and supernatants were collected. Protein concentrations were determined using the
BioRad protein assay (Bio-Rad Laboratories, Hercules, CA, USA) with BSA as a standard.
Nuclear extracts were prepared using the Nuclear Extraction Kit (Imgenex, San Diego, CA), according to the manufacturer s’
instructions. Nuclear protein concentrations were determined using the DC BioRad protein assay (Bio-Rad Laboratories) with BSA as a
standard.
Immunoblot analysis
Proteins were resolved by 8  or 10  SDS/PAGE and transferred onto polyvinylidene fluoride membranes. Membranes were then% %
blocked for 1h in 5  non fat dried milk in 10mM Tris, 150 mM NaCl and 0.1  Tween 20, pH 7.6 (TBST) and incubated overnight at 4 C% % °
with antibodies directed against TLR4 (dilution 1:250, sc-10741, Santa Cruz Biotechnology), NF- B p65 (dilution 1:3,000, sc-372, Santaκ
Cruz Biotechnology), NF- B p50 (dilution 1:1,000, sc-7178 Santa Cruz Biotechnology), PDE4B (K118, dilution 1:2,000, kindly donatedκ
by Dr M. Conti, Stanford University, CA, ( )) or -actin (dilution 1:2,000, A-2006, Sigma). After washing, membranes were incubated24 β
with HRP-conjugated rabbit secondary antibodies (dilution 1:7,000, sc-2313, Santa Cruz Biotechnology) and immunoreactive bands were
visualised by chemiluminescence (Amersham Biosciences ECL reagents, GE Healthcare, Buckinghamshire, UK).
Measurement of TNF  and MCP1α
Detection of TNF  in the supernatant of cultured chorionic cells was performed with an ELISA kit (Pierce, Rockford, IL) according toα
the manufacturer s instructions. Sensitivity of the kit was < 2 pg/ml and the standard curve range was 16 1,000 pg/ml. Detection of MCP1’ –
was performed using the Searchlight multiplex sample testing by Endogen, PerbioScience (Berbieres, France). ™
cAMP-phosphodiesterase assay
Aliquots of the cell lysates were assayed for cAMP-PDE activity according to the method of Thompson and Appleman as detailed
previously ( ). PDE activities were measured with 1 M H -cAMP as a substrate. PDE4 activity was defined as the fraction of25 μ [3 ]
cAMP-PDE activity inhibited by 10 M rolipram and expressed in pmoles/min/mg protein.5 −
Electrophoretic Mobility Shift Assay
Binding reactions were performed with 5 g of nuclear extracts from chorionic cells, using the LightShift Chemiluminescent EMSAμ
kit (Pierce) with 1x binding buffer, 50 ng/ l poly (dI.dC), 5  glycerol, 0.05  NP-40, 0.5 mM EDTA and 20 fmol biotin end-labeled NF-μ % % κ
B p65 oligonucleotide probe (5 -AGTTGAG CAGGCAG CAGGC-3 ) for 20 min. NF- B sites′ GGGAACTTCC GGGAATTTCC ′ κ
(underlined) correspond to the sequences described in the MCP-1 promoter ( ). After addition of the loading buffer, complexes were26 
separated on a 6  non denaturing polyacrylamide gel in 0.5X TBE and then transferred onto a nylon membrane. Complexes were fixed by%
UV exposure and visualized by chemiluminescence. For supershift analysis, 5 g nuclear extracts were pre-incubated for 1h at 4 C with 1 μ °
g antibodies directed against NF- B p65 (sc-372, Santa Cruz Biotechnology) or NF- B p50 (sc- 7178, Santa Cruz Biotechnology) beforeμ κ κ
addition of the labelled probe.
Statistical analysis
The significance of the difference was assessed by Kruskall-Wallis test followed by a Wilcoxon matched pair test using the
Prism-Graph Pad software (GraphPad Software). The difference was considered significant when was < 0.05.p 
Results
Characterization of dispersed chorionic cells
As observed by immunofluorescence analysis, routine preparation of chorionic cells yield to a mixed combination of CK7-positive
cells (trophoblasts, >90  of the total cells), CD45-positive cells (macrophages, 1 5  of the total cells) and vimentin-positive cells% – %
(mesenchymal cells, 1 5 ) after 24h of culture. After 72h of culture, trophoblasts clustered and were present as clumps or scarce single– %
cells, macrophages remained as single cells and mesenchymal cells covered the remaining space of the wells ( ). Depletion of theFigure 1 
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macrophages during the isolation of the cells did not affect the microscopic aspects of the chorionic cells after 72h of culture, whereas
depletion of mesenchymal cells induced major death of CK7-positive cells (data not shown).
Functional response of chorionic cells to LPS
Chorionic cell preparations were performed without or with depletion of the macrophages and challenged with 100 ng/mL of LPS. The
pro-inflammatory cytokines MCP-1 and TNF  concentrations were measured in the cell medium ( ). In the presence ofα Figure 2 
macrophages, MCP-1 was present in the culture medium in the control condition, whereas TNF  was merely detectable. LPS induced aα
significant increase of MCP-1 and TNF  concentrations in the culture medium. After depletion of the macrophages, MCP-1 and TNFα α
were detected in a small amount in the culture medium in the control condition and were not induced by LPS. Because resident
macrophages in the chorionic leave of fetal membranes are described throughout pregnancy and because we can not rule out a cooperation
of chorionic trophoblasts and macrophages in the response to LPS in term of cytokine production, we performed the next experiments with
cell preparations not depleted in macrophages.
TLR4 expression by chorionic cells
The expression of TLR4, the main LPS receptor, was investigated in human chorionic cells by western blot, revealing a unique band
of 96 kDa corresponding to TLR4 ( ). The intensity of the band remained unchanged upon LPS challenge ( ), indicating that27 Fig 3 
chorionic cells constitutively express TLR4 and this receptor is not regulated by LPS in these cells.
Induction of PDE4 by LPS in chorionic cells
We measured the cAMP-PDE activity in chorionic cells challenged by the endotoxin. As shown in , PDE4 activity wasFig 4A 
predominant in chorionic cells, as it represents more than 58  of the total cAMP-PDE activity in basal condition, and increased%
significantly in the presence of LPS. PDE4 activity reached a maximum at 2h of LPS treatment and then declined up to 8h. The non-PDE4
activity increased slightly but the difference failed to reach significance, suggesting that the effect of LPS on cAMP-PDE activity was
limited to PDE4 activity.
Western blot analysis ( ) performed with the PDE4B specific antibodies K118 revealed three bands, two that migrated at aboutFig. 4B 
80 kDa and one that migrated at about 70 kDa. Among the two close bands, the upper signal was first described as a protein corresponding
to the short form product of the PDE4B gene, the PDE4B2 isoform ( ). This band, almost undetectable in non-treated cells, appeared at28 
1h upon LPS treatment. The lower signal was described as nonspecific in human samples and the 70 kDa-band was previously reported as
non-specific with the K118 antibody ( ). Positive control done in differentiated U937 ( ), show the same three bands pattern with24 29 
K118. These data suggest that the specific isoform PDE4B2 is involved in the LPS-induced inflammatory pathway in chorionic cells.
PDE4 inhibition blocks LPS-induced TNF  secretion in chorionic cellsα
We investigated the effect of the PDE4 inhibitor rolipram on the release of TNF , induced by LPS in chorionic cells. As shown in α Fig
, TNF  concentration increased to reach a maximum at 8h of LPS treatment and declined to basal level after 24h. In the presence of5A α
rolipram, TNF  release is reduced as soon as 1h of treatment and plateaus at 4h. At this time point, LPS induced a TNF  releaseα α
significantly different from control and rolipram alone conditions ( ). Addition of rolipram to LPS significantly reduced the TNFFig 5B α
release. These data indicate that the PDE4 inhibitor has an anti-inflammatory effect on LPS-stimulated chorionic cells.
PDE4 inhibition reduces LPS-induced NF- B p65 translocation in chorionic cellsκ
As the stimulation of TLR4 triggers the activation of NF- B, starting with its nuclear translocation, we investigated byκ
immunofluorescence whether rolipram affects the effect of LPS on the cellular localization of the p65 subunit of NF- B in chorionic cells (κ
). In the control cells, p65 was mainly localized in the cytoplasm of clustered cells and single cells. Addition of LPS for 2hFig 6A 
triggered a translocation of p65 from the cytoplasm into the nucleus which was partially blocked in the presence of rolipram. Rolipram
alone had no effect on the nuclear translocation of p65.
To evaluate the magnitude of the rolipram effect on LPS-induced translocation of p65, the percentage of cells showing a nuclear
immunostaining was determined ( ). LPS treated cells showed a significant difference from control and rolipram conditions.Fig 6B 
Addition of rolipram to LPS significantly reduced the number of p65-stained nuclei.
The presence of the p65 subunit of NF- B in the chorionic cell nuclei was also confirmed by Western Blot analysis ( ). A bandκ Fig 6C 
that migrated at 65 kDa was detected in non-treated cells and its intensity was increased in cells treated by LPS. In cells treated by
rolipram alone and rolipram in addition to LPS, the intensity of the band was comparable to the one observed in basal condition.
These data indicate that LPS activates the NF- B pathway in chorionic cells and that PDE4 inhibition reduces the LPS-induced nuclearκ
translocation of NF- B p65.κ
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PDE4 inhibition decreases LPS-induced NF- B binding activity in chorionic cellsκ
In order to assess whether rolipram affects the increase in NF- B binding activity induced by LPS, we performed electrophoreticκ
mobility shift assay on nuclear extracts of chorionic cells. As shown in , two NF- B complexes were present under controlFig 7A κ
condition. Intensity of these complexes was increased as early as 1h after LPS treatment and peaked at 2h. A third weak complex that
migrated slower appeared at 2h of LPS treatment. The addition of rolipram strongly reduced the activation of the two fast complexes and
suppressed the third complex.
Supershift analysis was performed to further identify the subunits of the NF- B complexes present at 2h, the peak time point ofκ
activation ( ). Addition of antibodies against the p50 protein supershifted the fast and middle complexes. Antibodies against p65Fig 7B 
decreased the binding activity of the slow weak complex as well as the middle complex. This indicated that the fast activated complex in
chorionic cells consisted of a p50 homodimer, the middle complex consisted of a p65 and p50 heterodimer and the weak slow complex
consisted of a p65 homodimer.
These results suggest that three different NF- B complexes having a DNA binding activity in LPS-stimulated chorionic cells areκ
sensitive to PDE4 inhibition.
Discussion
Knowing the causal link between intrauterine inflammation and preterm birth, it is essential to understand the mechanisms that take
place at the feto-maternal interface to develop strategies preventing this event. In this study, we showed that the PDE4 inhibitor rolipram
has an anti-inflammatory effect on LPS-stimulated chorionic cells. Upon LPS stimulation, the transcription factor NF- B is activated inκ
these cells which release the pro-inflammatory cytokines TNF  and MCP-1. PDE4 inhibition reduces this NF- B activation. Because NF-α κ κ
B is thought to have a central role in human preterm labor, selective targeting of its activation at the feto-maternal interface may offer an
alternative way to prevent preterm delivery.
Several teams have developed protocols to isolate disperse chorionic cells; the most widely used is adapted from the Kilman s protocol’
to isolate villous trophoblast of the placenta, as in the current study. These protocols yield to an enriched preparation of CK7-positive cells,
i.e. trophoblasts, and a workshop about primary culture of trophoblasts recommended using preparations with 50  or more CK7human %
positive cells ( ). We routinely obtained more than 90  of CK7 positive cells with little contamination by macrophages and30 %
mesenchymal cells. In order to improve purity of the preparation, methods based on negative selection can be used; however we found
major changes in the survival of isolated trophoblasts in the absence of mesenchymal cells and in the global response to the endotoxin LPS
of the chorionic cells in the absence of macrophages. Because chorionic leave of fetal membranes is composed mainly of chorionic
trophoblasts, but also of mesenchyme and extracellular matrix as well as of resident macrophages, our chorionic cells model reflects this
specific combination of cells.
Chorion leave is in the direct contact with the maternal decidua and the cervix and in the vicinity of the myometrium throughout
pregnancy. Because chorionic cells metabolize prostaglandins throughout pregnancy and this function is modified towards parturition, it
has been postulated that these cells regulate myometrial contractility at term and preterm ( ). Herein, we provide evidence that TLR4,31 
the main LPS receptor, is expressed by human chorionic cells and is not regulated by LPS. Moreover, chorionic cells respond functionally
to LPS in that they produce the proinflammatory cytokines TNF  and MCP-1. As described in human choriodecidua ( ), PDE4 activityα 21 
is also predominant in cultured human chorionic cells. PDE4 activity was increased in these cells upon LPS challenge and the expression
of the specific isoform PDE4B2 was induced. PDE4 was previously reported to be predominant in monocytes and macrophages, wherein
LPS strongly stimulates the mRNA expression of the PDE4B subtype, and in neutrophils, wherein PDE4B is constitutively expressed at
high levels. The specific isoform implicated in the PDE4 activity increase under LPS in monocytes was identified as PDE4B2 ( , , 19 32 33 
). It is well-documented that PDE4-selective inhibitors produce profound inhibitory effect on LPS-stimulated TNF  production inα
circulating monocytes ( ). The use of mice deficient in PDE4B gene allowed to determine that the PDE4B induction by LPS was34 
responsible for the two-thirds of the TNF  production in monocytes and macrophages ( ). In our model of chorionic cells, we haveα 32 
shown that the inhibition of PDE4 by rolipram decreased the TNF  release in the same proportion than in leukocytes. As we were able toα
identify an upregulation of the specific isoform PDE4B2 in chorionic cells, we suggest that PDE4B2 is involved in the LPS-induced TNFα
production in these cells. Such data, together with our previous studies, confirm PDE4B2 as a promising pharmaceutical target in the
management of preterm labor related to inflammation. PDE4 inhibitors have been developed for use in a variety of human health
conditions such as depression, asthma, or inflammatory disorders. Heretofore their most frequent adverse effects, namely nausea and
emesis, and high dosage dependent cases of arteritis in rodents and dog have hindered their therapeutic application ( ). Although not yet35 
available, we can expect that specific PDE4 subtype inhibitors such as PDE4B2 inhibitors may result in a broader safety window
compatible with a clinical use during pregnancy.
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An examination of the molecular mechanisms of LPS-induced inflammation in chorionic cells has shown the nuclear translocation of
the p65 subunit of NF- B and the global activation of three distinct NF- B complexes. A fraction of p50/p50 was already active in controlκ κ
conditions while NF- B complexes containing p65 were activated by LPS. Because p50 lacks of a transactivation domain, p50/p50 isκ
thought to be a repressor of transcription that would explained its presence in control conditions ( ). Conversely, p65 subunit is a potent36 
transcriptional activator ( ). Schreiber et al ( ) demonstrated that the different NF- B family members act coordinately to regulate gene37 38 κ
expression in LPS-stimulated human monocytes. They have shown that p50 is bound to the promoters of many NF- B target genes inκ
resting cells while p65 binds to its target genes, including some prebound by p50, only in LPS stimulated cells. In the chorionic cells, a
part of complexity in the NF- B signaling is supplied by the presence of three complexes; each one could be responsible for the activationκ
and/or repression of specific genes. The PDE4 inhibition partially blocked the p65 nuclear translocation and reduced the NF- B globalκ
binding activity. Prevention of NF- B nuclear translocation by rolipram was previously shown in a LPS-induced uveitis model in rat ( )κ 39 
and in a LPS-induced preterm delivery model in mouse ( ). Our data highlight an involvement of PDE4 in the NF- B signaling of20 κ
human chorionic cells and such interaction may be a key event in the fetal response to inflammation. Moreover because nuclear
translocation of NF- B-p65 subunit was observed in most of the cells, cooperation in a paracrine manner between trophoblasts and theκ
other cell types at the feto-maternal interface may occur in response to LPS.
In conclusion, human chorionic cells are able to mount an inflammatory response against bacterial products that is readily reduced by
PDE4 inhibition. Our previous works showed that PDE4 inhibition is not only able to abolish metalloprotease activation and prostaglandin
synthesis in fetal membranes but is also able to block spontaneous contractions of myometrial strips ( , ). Given its dual myorelaxant21 40 
and anti-inflammatory properties ( ), selective PDE4 inhibition may represent a novel approach in the management of41 
inflammation-induced preterm delivery.
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 PDE : phosphodiesterase
 CK7 : cytokeratin 7
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Fig 1
Characterization of cultured chorionic cells
Immunofluorescence analysis of CK7 (A), vimentin (B) and CD45 (C) in cultured chorionic cells showed the clustered pattern of
trophoblasts, the expansion of mesencymal cells and a few macrophages.
Effect of PDE4 inhibition in chorionic cells
J Immunol . Author manuscript
Page /8 13
Fig 2
Response of chorionic cells to LPS in the presence and in the absence of macrophages
Concentration of TNF  and MCP1 were measured in cell media collected after 4h of treatment with LPS 100 ng/ml or its diluent. The cellα
preparations were either or not depleted of CD45 positive cells. Data are expressed as the mean  sem of 5 different preparations. , p < 0.05,± *
significantly different from control, not CD45-depleted cell preparation
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Fig 3
Analysis of TLR4 expression by chorionic cells
Lysates of cells treated with LPS 100 ng/mL for the indicated times were subjected to Western Blot (15 g of proteins per lane) and probedμ
with the TLR4 antibodies. Lysate of U937 cells served as a positive control. The detection of -actin in each sample served as a loadingβ
control. A representative experiment is shown, reproduced 3 times.
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Fig 4
Induction of PDE4 by LPS in chorionic cells
A. Time-dependent effect of LPS on PDE4 activity. Data reported the mean  SEM of 4 separate experiments. , p < 0.01. B. Effect of LPS± **
on the PDE4B expression. Lysates of cells treated with LPS 100 ng/mL for the indicated times were subjected to Western Blot (15 g ofμ
proteins per lane) and probed with the PDE4B antibodies. Lysate of U937 cells served as a positive control. A representative experiment is
shown, reproduced 3 times.
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Fig 5
Effect of LPS and rolipram on TNF  secretion by chorionic cellsα
A. Time-course of TNF  secretion by chorionic cells. Cells were incubated in the absence or the presence of LPS 100 ng/mL with or withoutα
rolipram 10 M for the indicated times. A representative experiment is shown, data reported the mean  SD of triplicates in the assay,5 − ±
reproduced 3 times. B. Chorionic cells of 10 different placentas were incubated in the absence or presence of LPS with or without rolipram for
4h. Data are expressed as the mean  SEM of the 10 separate experiments. , p < 0.01, significantly different from control and rolipram. , p <± *  #
0.01, significantly different from LPS treatment.
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Fig 6
Effect of LPS and rolipram on the NF- B p65 nuclear translocation in chorionic cellsκ
A. p65 nuclear translocation assessed by immunofluorescence under LPS 100 ng/mL with or without rolipram 10 M for 2h. A representative5 −
experiment is shown, reproduced 7 times. B. Chorionic cells were incubated in the absence or in the presence of LPS and rolipram for 2h. p65
nuclear translocation was assessed by immunofluorescence and quantified as described in Materiel and Methods. Data are expressed as the
mean  SEM of the 7 separate experiments. , p < 0.05, significantly different from control and rolipram. , p < 0.01, significantly different± *  #
from LPS treatment. C. Nuclear extracts from chorionic cells treated with LPS with or without rolipram for 2h were subjected to Western Blot
(25 g of proteins per lane) and probed with the p65 antibodies. The detection of -actin in each sample served as a loading control. Aμ β
representative experiment is shown, reproduced 3 times.
Effect of PDE4 inhibition in chorionic cells
J Immunol . Author manuscript
Page /13 13
Fig 7
Effect of LPS and rolipram on the NF- B binding activity in chorionic cells. Representative experiments are shown, reproduced 3 times. A.κ
Time-course of NF- B binding activity in chorionic cells under LPS 100 ng/mL with or without rolipram 10 M. Nuclear extracts fromκ 5 −
chorionic cells were incubated with biotin end-labeled oligonucleotides containing the NF- B consensus sequence and subjected to EMSA. B.κ
Supershift analysis of the NF- B complexes present at 2h of LPS treatment. Nuclear extracts were pre-incubated with antibodies against p50κ
or p65.
